Skip to Main Content

Paper Details

Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives.
Cancers (Basel)
21
2022
Author NameAffiliation
Carmen CriscitielloEuropean Institute of Oncology IRCCS
Carmen CriscitielloUniversity of Milan
Alberto ZambelliHumanitas University
Alberto ZambelliIRCCS Humanitas Research Hospital, Humanitas Cancer Center
  • 1 - 4

Datasets

Release 1.2